{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:09:43Z","timestamp":1794035383790,"version":"4.8.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-67939-3","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T16:56:58Z","timestamp":1769101018000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Longitudinal plasma proteomic signatures of elite and viremic spontaneous HIV controllers"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1746-8844","authenticated-orcid":false,"given":"Nadira","family":"Vadaq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2072-2532","authenticated-orcid":false,"given":"Albert L.","family":"Groenendijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9ssica C.","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3076-9262","authenticated-orcid":false,"given":"Kavita","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2066-8115","authenticated-orcid":false,"given":"Ferdinand W.N.M.","family":"Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3716-4390","authenticated-orcid":false,"given":"Wilhelm A. J. W.","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martinus J. T.","family":"Blaauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise E.","family":"van Eekeren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1415-4591","authenticated-orcid":false,"given":"Laurens","family":"Lambrechts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4623-0939","authenticated-orcid":false,"given":"Sofie","family":"Rutsaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4064-5412","authenticated-orcid":false,"given":"Erni J.","family":"Nelwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Jian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6166-9830","authenticated-orcid":false,"given":"Leo A. B.","family":"Joosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6056-157X","authenticated-orcid":false,"given":"Quirijn","family":"de Mast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5852-6801","authenticated-orcid":false,"given":"Vasiliki","family":"Matzaraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"van Lunzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1904-6450","authenticated-orcid":false,"given":"Casper","family":"Rokx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"Verbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2421-6052","authenticated-orcid":false,"given":"Mihai G.","family":"Netea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8600-1631","authenticated-orcid":false,"given":"Linos","family":"Vandekerckhove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1833-3391","authenticated-orcid":false,"given":"Andr\u00e9 J. A. M.","family":"van der Ven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"67939_CR1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/QAD.0000000000000049","volume":"28","author":"D Gurdasani","year":"2014","unstructured":"Gurdasani, D. et al. A systematic review of definitions of extreme phenotypes of HIV control and progression. AIDS 28, 149\u2013162 (2014).","journal-title":"AIDS"},{"key":"67939_CR2","doi-asserted-by":"publisher","first-page":"100963","DOI":"10.1016\/j.eclinm.2021.100963","volume":"37","author":"L Pla\u00e7ais","year":"2021","unstructured":"Pla\u00e7ais, L. et al. Antiretroviral therapy for HIV controllers: Reasons for initiation and outcomes in the French ANRS-CO21 CODEX cohort. eClinicalMedicine 37, 100963 (2021).","journal-title":"eClinicalMedicine"},{"key":"67939_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/hiv.12820","volume":"21","author":"R Brusca","year":"2020","unstructured":"Brusca, R. et al. Subclinical cardiovascular disease in HIV controller and long-term nonprogressor populations. HIV Med. 21, 217\u2013227 (2020).","journal-title":"HIV Med."},{"key":"67939_CR4","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1093\/cid\/ciw120","volume":"62","author":"B Dominguez-Molina","year":"2016","unstructured":"Dominguez-Molina, B. et al. Analysis of non-AIDS-defining events in HIV controllers. Clin. Infect. Dis. 62, 1304\u20131309 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"67939_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-19970-3","volume":"12","author":"L Capa","year":"2022","unstructured":"Capa, L. et al. Elite controllers long-term non progressors present improved survival and slower disease progression. Sci. Rep. 12, 16356 (2022).","journal-title":"Sci. Rep."},{"key":"67939_CR6","doi-asserted-by":"publisher","first-page":"982746","DOI":"10.3389\/fimmu.2022.982746","volume":"13","author":"W Vos","year":"2022","unstructured":"Vos, W. et al. The 2000HIV study: Design, multi-omics methods and participant characteristics. Front Immunol. 13, 982746 (2022).","journal-title":"Front Immunol."},{"key":"67939_CR7","doi-asserted-by":"crossref","unstructured":"Ros\u00e1s-Umbert, M. et al., Mechanisms of abrupt loss of virus control in a cohort of previous HIV controllers. J. Virol. 93, e01436-18 (2019).","DOI":"10.1128\/JVI.01436-18"},{"key":"67939_CR8","unstructured":"Gasca-Capote, C., et al., The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers. J. Clin. Invest. 134, e174215 (2024)."},{"key":"67939_CR9","doi-asserted-by":"crossref","unstructured":"Hartana, C. A. & Yu, X. G. Immunological effector mechanisms in HIV-1 elite controllers. Current Opinion in HIV and AIDS 16, 243\u2013248 (2021).","DOI":"10.1097\/COH.0000000000000693"},{"key":"67939_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41586-020-2651-8","volume":"585","author":"C Jiang","year":"2020","unstructured":"Jiang, C. et al. Distinct viral reservoirs in individuals with spontaneous control of HIV-1. Nature 585, 261\u2013267 (2020).","journal-title":"Nature"},{"key":"67939_CR11","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.cell.2016.06.039","volume":"166","author":"EA Boritz","year":"2016","unstructured":"Boritz, E. A. et al. Multiple origins of virus persistence during natural control of HIV infection. Cell 166, 1004\u20131015 (2016).","journal-title":"Cell"},{"key":"67939_CR12","doi-asserted-by":"publisher","first-page":"eabl4097","DOI":"10.1126\/scitranslmed.abl4097","volume":"13","author":"X Lian","year":"2021","unstructured":"Lian, X. et al. Signatures of immune selection in intact and defective proviruses distinguish HIV-1 elite controllers. Sci. Transl. Med 13, eabl4097 (2021).","journal-title":"Sci. Transl. Med"},{"key":"67939_CR13","unstructured":"Gasca-Capote, C. et al. The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers. J. Clin. Invest. 134, e174215 (2024)."},{"key":"67939_CR14","doi-asserted-by":"publisher","first-page":"e02490-21","DOI":"10.1128\/mBio.02490-21","volume":"12","author":"FH Omondi","year":"2021","unstructured":"Omondi, F. H. et al. HIV proviral burden, genetic diversity, and dynamics in viremic controllers who subsequently initiated suppressive antiretroviral therapy. mBio 12, e02490-21 (2021).","journal-title":"mBio"},{"key":"67939_CR15","doi-asserted-by":"publisher","first-page":"763039","DOI":"10.3389\/fmicb.2022.763039","volume":"13","author":"S P\u00e9rez-Yanes","year":"2022","unstructured":"P\u00e9rez-Yanes, S. et al. The characteristics of the HIV-1 Env glycoprotein are linked with viral pathogenesis. Front. Microbiol. 13, 763039 (2022).","journal-title":"Front. Microbiol."},{"key":"67939_CR16","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1093\/infdis\/jiy599","volume":"219","author":"E Rodr\u00edguez-Gallego","year":"2018","unstructured":"Rodr\u00edguez-Gallego, E. et al. Proteomic profile associated with loss of spontaneous human immunodeficiency virus type 1 elite control.  J. Infect. Dis. 219, 867\u2013876 (2018).","journal-title":"J. Infect. Dis."},{"key":"67939_CR17","doi-asserted-by":"crossref","unstructured":"Guti\u00e9rrez-Rivas, M. et al., High plasma levels of sTNF-R1 and CCL11 are related to CD4+ T-cells fall in human immunodeficiency virus elite controllers with a sustained virologic control. Front Immunol. 18, 1399 (2018).","DOI":"10.3389\/fimmu.2018.01399"},{"key":"67939_CR18","doi-asserted-by":"publisher","first-page":"100287","DOI":"10.1016\/j.xcrm.2021.100287","volume":"2","author":"MR Filbin","year":"2021","unstructured":"Filbin, M. R. et al. Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions. Cell Rep. Med. 2, 100287 (2021).","journal-title":"Cell Rep. Med."},{"key":"67939_CR19","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/eji.202149532","volume":"52","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z. et al. Intestinal homeostasis and inflammation: Gut microbiota at the crossroads of pancreas\u2013intestinal barrier axis. Eur. J. Immunol. 52, 1035\u20131046 (2022).","journal-title":"Eur. J. Immunol."},{"key":"67939_CR20","doi-asserted-by":"crossref","unstructured":"Groenendijk, A. L. et al. The risk of non-AIDS defining events is lower in ART-naive HIV controllers than in normal progressors on suppressive ART. Clin Infect Dis. 80, 585\u2013593 (2024).","DOI":"10.1093\/cid\/ciae440"},{"key":"67939_CR21","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jneuroim.2005.09.017","volume":"171","author":"G Pati\u00f1o-Lopez","year":"2006","unstructured":"Pati\u00f1o-Lopez, G. et al. Human class-I restricted T cell associated molecule is highly expressed in the cerebellum and is a marker for activated NKT and CD8+ T lymphocytes. J. Neuroimmunol. 171, 145\u2013155 (2006).","journal-title":"J. Neuroimmunol."},{"key":"67939_CR22","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1182\/blood-2005-02-0817","volume":"106","author":"KS Boles","year":"2005","unstructured":"Boles, K. S. et al. The tumor suppressor TSLC1\/NECL-2 triggers NK-cell and CD8+ T-cell responses through the cell-surface receptor CRTAM. Blood 106, 779\u2013786 (2005).","journal-title":"Blood"},{"key":"67939_CR23","doi-asserted-by":"crossref","unstructured":"Class I-Restricted T Cell-Associated Molecule Is a Marker for IFN-\u03b3-Producing iNKT Cells in Healthy Subjects and Patients with Type 1 Diabetes. J. Interferon & Cytokine Res. 37, 39\u201349 (2017).","DOI":"10.1089\/jir.2016.0006"},{"key":"67939_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1084\/jem.20150519","volume":"213","author":"A Takeuchi","year":"2016","unstructured":"Takeuchi, A. et al. CRTAM determines the CD4+ cytotoxic T lymphocyte lineage. J. Exp. Med 213, 123\u2013138 (2016).","journal-title":"J. Exp. Med"},{"key":"67939_CR25","doi-asserted-by":"crossref","unstructured":"Patil, V. S. et al. Precursors of human CD4(+) cytotoxic T lymphocytes identified by single-cell transcriptome analysis. Sci. Immunol. 3, eaan8664 (2018).","DOI":"10.1126\/sciimmunol.aan8664"},{"key":"67939_CR26","doi-asserted-by":"publisher","first-page":"e9759","DOI":"10.1097\/MD.0000000000009759","volume":"97","author":"M Sperk","year":"2018","unstructured":"Sperk, M. et al. Plasma soluble factor following two decades prolonged suppressive antiretroviral therapy in HIV-1-positive males: A cross-sectional study. Med. (Baltim.) 97, e9759 (2018).","journal-title":"Med. (Baltim.)"},{"key":"67939_CR27","doi-asserted-by":"publisher","first-page":"291","DOI":"10.4049\/jimmunol.176.1.291","volume":"176","author":"DB Graham","year":"2006","unstructured":"Graham, D. B. et al. Ly9 (CD229)-deficient mice exhibit T cell defects yet do not share several phenotypic characteristics associated with SLAM- and SAP-deficient mice. J. Immunol. 176, 291\u2013300 (2006).","journal-title":"J. Immunol."},{"key":"67939_CR28","doi-asserted-by":"publisher","first-page":"9321","DOI":"10.1073\/pnas.1605081113","volume":"113","author":"D Comte","year":"2016","unstructured":"Comte, D. et al. Engagement of SLAMF3 enhances CD4+ T-cell sensitivity to IL-2 and favors regulatory T-cell polarization in systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 113, 9321\u20139326 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67939_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1791-y","volume":"10","author":"T Zhou","year":"2019","unstructured":"Zhou, T. et al. Upregulation of SLAMF3 on human T cells is induced by palmitic acid through the STAT5-PI3K\/Akt pathway and features the chronic inflammatory profiles of type 2 diabetes. Cell Death Dis. 10, 559 (2019).","journal-title":"Cell Death Dis."},{"key":"67939_CR30","doi-asserted-by":"publisher","first-page":"7033","DOI":"10.4049\/jimmunol.174.11.7033","volume":"174","author":"X Romero","year":"2005","unstructured":"Romero, X. et al. CD229 (Ly9) lymphocyte cell surface receptor interacts homophilically through its N-terminal domain and relocalizes to the immunological synapse. J. Immunol. 174, 7033\u20137042 (2005).","journal-title":"J. Immunol."},{"key":"67939_CR31","doi-asserted-by":"crossref","unstructured":"Roncador, G. et al. CD229 (Ly9), a novel biomarker for B-cell malignancies and multiple myeloma. Cancers (Basel), 14, 2154 (2022).","DOI":"10.3390\/cancers14092154"},{"key":"67939_CR32","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1038\/s41564-022-01264-z","volume":"7","author":"ID Irwan","year":"2022","unstructured":"Irwan, I. D., Bogerd, H. P. & Cullen, B. R. Epigenetic silencing by the SMC5\/6 complex mediates HIV-1 latency. Nat. Microbiol 7, 2101\u20132113 (2022).","journal-title":"Nat. Microbiol"},{"key":"67939_CR33","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1093\/rheumatology\/40.9.1056","volume":"40","author":"M Ramos-Casals","year":"2001","unstructured":"Ramos-Casals, M. et al. High circulating levels of soluble scavenger receptors (sCD5 and sCD6) in patients with primary Sj\u00f6gren\u2019s syndrome. Rheumatol. (Oxf.) 40, 1056\u20131059 (2001).","journal-title":"Rheumatol. (Oxf.)"},{"key":"67939_CR34","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.jcrc.2015.04.120","volume":"30","author":"J Aibar","year":"2015","unstructured":"Aibar, J. et al. Pattern of soluble CD5 and CD6 lymphocyte receptors in critically ill patients with septic syndromes. J. Crit. Care 30, 914\u2013919 (2015).","journal-title":"J. Crit. Care"},{"key":"67939_CR35","doi-asserted-by":"crossref","unstructured":"A Role for Scavenger-like Lymphocyte Receptor CD6 in HIV-1 Viral Infection. AIDS Research and Human Retroviruses, 30, A49\u2013A50 (2014).","DOI":"10.1089\/aid.2014.5085.abstract"},{"key":"67939_CR36","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0014-5793(93)81140-U","volume":"315","author":"M Linial","year":"1993","unstructured":"Linial, M. & Levius, O. VAT-1 from Torpedo is a membranous homologue of zeta crystallin. FEBS Lett. 315, 91\u201394 (1993).","journal-title":"FEBS Lett."},{"key":"67939_CR37","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","volume":"14","author":"C Franceschi","year":"2018","unstructured":"Franceschi, C. et al. Inflammaging: a new immune\u2013metabolic viewpoint for age-related diseases. Nat. Rev. Endocrinol. 14, 576\u2013590 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"key":"67939_CR38","doi-asserted-by":"publisher","first-page":"822272","DOI":"10.3389\/fimmu.2022.822272","volume":"13","author":"J Masip","year":"2022","unstructured":"Masip, J. et al. Elevated \u03b1-ketoglutaric acid concentrations and a lipid-balanced signature are the key factors in long-term HIV control. Front Immunol. 13, 822272 (2022).","journal-title":"Front Immunol."},{"key":"67939_CR39","doi-asserted-by":"crossref","unstructured":"Pernas, M. et al. Factors leading to the loss of natural elite control of HIV-1 infection. J. Virol. 92, e01805-17 (2018).","DOI":"10.1128\/JVI.01805-17"},{"key":"67939_CR40","doi-asserted-by":"publisher","first-page":"e0131922","DOI":"10.1371\/journal.pone.0131922","volume":"10","author":"N Noel","year":"2015","unstructured":"Noel, N. et al. Immunologic and virologic progression in hiv controllers: the role of viral \u201cblips\u201d and immune activation in the ANRS CO21 CODEX study. PLoS One 10, e0131922 (2015).","journal-title":"PLoS One"},{"key":"67939_CR41","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1083\/jcb.123.4.1007","volume":"123","author":"MR Campanero","year":"1993","unstructured":"Campanero, M. R. et al. ICAM-3 interacts with LFA-1 and regulates the LFA-1\/ICAM-1 cell adhesion pathway. J. Cell Biol. 123, 1007\u20131016 (1993).","journal-title":"J. Cell Biol."},{"key":"67939_CR42","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1002\/(SICI)1521-4141(199907)29:07<2248::AID-IMMU2248>3.0.CO;2-9","volume":"29","author":"DA Bleijs","year":"1999","unstructured":"Bleijs, D. A. et al. Co-stimulation of T cells results in distinct IL-10 and TNF-alpha cytokine profiles dependent on binding to ICAM-1, ICAM-2 or ICAM-3. Eur. J. Immunol. 29, 2248\u20132258 (1999).","journal-title":"Eur. J. Immunol."},{"key":"67939_CR43","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/ni753","volume":"3","author":"MC Montoya","year":"2002","unstructured":"Montoya, M. C. et al. Role of ICAM-3 in the initial interaction of T lymphocytes and APCs. Nat. Immunol. 3, 159\u2013168 (2002).","journal-title":"Nat. Immunol."},{"key":"67939_CR44","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s10495-013-0873-z","volume":"18","author":"E Krist\u00f3f","year":"2013","unstructured":"Krist\u00f3f, E. et al. Novel role of ICAM3 and LFA-1 in the clearance of apoptotic neutrophils by human macrophages. Apoptosis 18, 1235\u20131251 (2013).","journal-title":"Apoptosis"},{"key":"67939_CR45","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/cdd.2011.167","volume":"19","author":"EE Torr","year":"2012","unstructured":"Torr, E. E. et al. Apoptotic cell-derived ICAM-3 promotes both macrophage chemoattraction to and tethering of apoptotic cells. Cell Death Differ. 19, 671\u2013679 (2012).","journal-title":"Cell Death Differ."},{"key":"67939_CR46","doi-asserted-by":"publisher","first-page":"6692","DOI":"10.1128\/JVI.78.12.6692-6697.2004","volume":"78","author":"C Barat","year":"2004","unstructured":"Barat, C., Gervais, P. & Tremblay, M. J. Engagement of ICAM-3 provides a costimulatory signal for human immunodeficiency virus type 1 replication in both activated and quiescent CD4+ T lymphocytes: implications for virus pathogenesis. J. Virol. 78, 6692\u20136697 (2004).","journal-title":"J. Virol."},{"key":"67939_CR47","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.virol.2007.03.017","volume":"364","author":"JE Biggins","year":"2007","unstructured":"Biggins, J. E. et al. ICAM-3 influences human immunodeficiency virus type 1 replication in CD4+ T cells independent of DC-SIGN-mediated transmission. Virology 364, 383\u2013394 (2007).","journal-title":"Virology"},{"key":"67939_CR48","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/1097-0215(20001101)88:3<439::AID-IJC17>3.0.CO;2-#","volume":"88","author":"N Nagy","year":"2000","unstructured":"Nagy, N. et al. SH2D1A and SLAM protein expression in human lymphocytes and derived cell lines. Int J. Cancer 88, 439\u2013447 (2000).","journal-title":"Int J. Cancer"},{"key":"67939_CR49","doi-asserted-by":"publisher","first-page":"11966","DOI":"10.1073\/pnas.0905691106","volume":"106","author":"N Nagy","year":"2009","unstructured":"Nagy, N. et al. The proapoptotic function of SAP provides a clue to the clinical picture of X-linked lymphoproliferative disease. Proc. Natl. Acad. Sci. 106, 11966\u201311971 (2009).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"67939_CR50","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1182\/blood-2003-09-3359","volume":"103","author":"R Sharifi","year":"2004","unstructured":"Sharifi, R. et al. SAP mediates specific cytotoxic T-cell functions in X-linked lymphoproliferative disease. Blood 103, 3821\u20133827 (2004).","journal-title":"Blood"},{"key":"67939_CR51","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/26683","volume":"395","author":"J Sayos","year":"1998","unstructured":"Sayos, J. et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 395, 462\u2013469 (1998).","journal-title":"Nature"},{"key":"67939_CR52","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.neuron.2016.04.001","volume":"90","author":"K Matsuda","year":"2016","unstructured":"Matsuda, K. et al. Transsynaptic modulation of kainate receptor functions by C1q-like proteins. Neuron 90, 752\u2013767 (2016).","journal-title":"Neuron"},{"key":"67939_CR53","doi-asserted-by":"publisher","first-page":"D1038","DOI":"10.1093\/nar\/gkac972","volume":"51","author":"T Groza","year":"2022","unstructured":"Groza, T. et al. The International mouse phenotyping consortium: comprehensive knockout phenotyping underpinning the study of human disease. Nucleic Acids Res. 51, D1038\u2013D1045 (2022).","journal-title":"Nucleic Acids Res."},{"key":"67939_CR54","doi-asserted-by":"publisher","first-page":"19621","DOI":"10.1073\/pnas.2013378117","volume":"117","author":"A Rein","year":"2020","unstructured":"Rein, A. The heart of the HIV RNA packaging signal?. Proc. Natl. Acad. Sci. USA 117, 19621\u201319623 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67939_CR55","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.02011-21","volume":"96","author":"K Fisher","year":"2022","unstructured":"Fisher, K. et al. Plasma-derived HIV-1 virions contain considerable levels of defective genomes. J. Virol. 96, e0201121 (2022).","journal-title":"J. Virol."},{"key":"67939_CR56","doi-asserted-by":"publisher","first-page":"10313","DOI":"10.1128\/JVI.01225-12","volume":"87","author":"F Maldarelli","year":"2013","unstructured":"Maldarelli, F. et al. HIV populations are large and accumulate high genetic diversity in a nonlinear fashion. J. Virol. 87, 10313\u201310323 (2013).","journal-title":"J. Virol."},{"key":"67939_CR57","doi-asserted-by":"publisher","first-page":"e022516","DOI":"10.1136\/bmjopen-2018-022516","volume":"8","author":"TS Boender","year":"2018","unstructured":"Boender, T. S. et al. AIDS Therapy Evaluation in the Netherlands (ATHENA) national observational HIV cohort: cohort profile. BMJ Open 8, e022516 (2018).","journal-title":"BMJ Open"},{"key":"67939_CR58","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/s42255-023-00753-7","volume":"5","author":"M Koprulu","year":"2023","unstructured":"Koprulu, M. et al. Proteogenomic links to human metabolic diseases. Nat. Metab. 5, 516\u2013528 (2023).","journal-title":"Nat. Metab."},{"key":"67939_CR59","doi-asserted-by":"publisher","first-page":"113307","DOI":"10.1016\/j.jim.2022.113307","volume":"507","author":"A Navas","year":"2022","unstructured":"Navas, A. et al. Comprehensive phenotyping of circulating immune cell subsets in people living with HIV. J. Immunol. Methods 507, 113307 (2022).","journal-title":"J. Immunol. Methods"},{"key":"67939_CR60","doi-asserted-by":"publisher","first-page":"110739","DOI":"10.1016\/j.celrep.2022.110739","volume":"39","author":"B Cole","year":"2022","unstructured":"Cole, B. et al. Extensive characterization of HIV-1 reservoirs reveals links to plasma viremia before and during analytical treatment interruption. Cell Rep. 39, 110739 (2022).","journal-title":"Cell Rep."},{"key":"67939_CR61","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman, B. T. et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 50, W216\u2013W221 (2022).","journal-title":"Nucleic Acids Res."},{"key":"67939_CR62","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.12688\/f1000research.9090.1","volume":"5","author":"M Kucera","year":"2016","unstructured":"Kucera, M. et al. AutoAnnotate: a cytoscape app for summarizing networks with semantic annotations. F1000Research 5, 1717 (2016).","journal-title":"F1000Research"},{"key":"67939_CR63","doi-asserted-by":"publisher","first-page":"e13984","DOI":"10.1371\/journal.pone.0013984","volume":"5","author":"D Merico","year":"2010","unstructured":"Merico, D. et al. Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS ONE 5, e13984 (2010).","journal-title":"PLoS ONE"},{"key":"67939_CR64","unstructured":"Groenendijk, A. L. HIV_controller_ATHENA. Github, (2025)."},{"key":"67939_CR65","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1093\/nar\/gkf436","volume":"30","author":"K Katoh","year":"2002","unstructured":"Katoh, K. et al. MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res 30, 3059\u20133066 (2002).","journal-title":"Nucleic Acids Res"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67939-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67939-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67939-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T17:03:55Z","timestamp":1769792635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67939-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["67939"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-67939-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"assertion":[{"value":"28 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The 2000HIV project was funded by ViiV Healthcare. ViiV Healthcare had no role in the conceptualization, design, data collection, analysis, decision to publish, or preparation of the manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1173"}}